Press Releases Items Per Page 102550 Year All2023202220212020201920182017201620152012 May 01, 2023 Galera Expands Commercial Leadership Team PDF Version Apr 26, 2023 Galera to Present One-Year Reductions in Cisplatin-Related Chronic Kidney Disease Data from ROMAN Trial at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting PDF Version Mar 10, 2023 Galera Announces Presentation of Supplemental Analysis of Phase 3 ROMAN Trial at European Congress on Head and Neck Oncology PDF Version Mar 08, 2023 Galera Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates PDF Version Feb 15, 2023 Galera Therapeutics Announces Pricing of Registered Direct Offering of $30 Million of Common Stock and Warrants PDF Version Feb 15, 2023 Galera Announces FDA Acceptance and Priority Review of Avasopasem NDA for Radiotherapy-Induced Severe Oral Mucositis PDF Version
Apr 26, 2023 Galera to Present One-Year Reductions in Cisplatin-Related Chronic Kidney Disease Data from ROMAN Trial at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting PDF Version
Mar 10, 2023 Galera Announces Presentation of Supplemental Analysis of Phase 3 ROMAN Trial at European Congress on Head and Neck Oncology PDF Version
Mar 08, 2023 Galera Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates PDF Version
Feb 15, 2023 Galera Therapeutics Announces Pricing of Registered Direct Offering of $30 Million of Common Stock and Warrants PDF Version
Feb 15, 2023 Galera Announces FDA Acceptance and Priority Review of Avasopasem NDA for Radiotherapy-Induced Severe Oral Mucositis PDF Version
